According to the Centers for Disease Control and Prevention (CDC), more than 29 million Americans have diabetes. Another 86 million adults in the U.S. suffer from prediabetes, which puts them at risk for developing the disease.
Because diabetes is such a major health crisis in the United States, it is not surprising that drug companies have begun to aggressively market drugs designed to treat blood sugar levels.
One drug, Onglyza, has recently come under scrutiny for safety concerns after patients developed cardiovascular problems while taking the drug.
What Is Onglyza?
Manufactured by Bristol-Myers-Squibb/AstraZeneca, Onglyza is a dipeptidyl peptidase-4 inhibitor that stimulates the body to produce insulin. Approved by the Food and Drug Administration (FDA) in 2009, Onglyza is one of a class of these drugs that has earned billions on the market.
According to a preliminary review by the FDA, Onglyza may be associated with an increased rate of death due to heart failure. Although the drug supposedly did not result in an increased risk of heart failure in clinical trials, a “more detailed analysis” of Onglyza revealed “a significantly increased risk of all-cause mortality.” The analysis, which was published in the New England Journal of Medicine, revealed a 27 percent increase in heart failure risk among diabetes patients taking the drug.
In February 2014, the FDA released a safety warning stating its concerns about Onglyza’s link to heart failure in diabetes patients. Although the FDA has not issued a recall, it has ordered Onglyza’s makers to include an additional warning on the label.
Since Onglyza hit the market, hundreds of individuals and families have come forward, claiming the drug led to heart failure. The lawsuits filed allege the drug maker failed to conduct enough testing to determine the drug was truly safe before offering it to consumers.
Georgia Dangerous Drug Law Firm
As a personal injury practitioner for two decades, as well as a licensed pharmacist, I know how devastating families feel when a loved one is lost due to a defective or dangerous pharmaceutical. If you have been injured while taking Onglyza, or you believe a loved one died due to heart failure caused by Onglyza, contact my office today at (912) 265-9811 to discuss your case.
This article has been prepared by J. Alan Welch Law for informational purposes only and does not, and is not intended to, constitute legal advice. The information is not provided in the course of an attorney-client relationship and is not intended to substitute for legal advice from an attorney licensed in your jurisdiction.